SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

UPDATE: Tetraphase Board Determine Melinta Offer Could Reasonably Be Expected To Lead To A Superior Offer As Defined In AcelRx Deal

Benzinga · 05/15/2020 10:40